Could Heart Implant Device Replace Drugs Like Multaq?
A new clinical trial of Boston Scientific’s Watchman implant device was conducted to see how it worked in stroke prevention for AF patients. According to the trial results, the device...
EMA Recommends ACS Indication for Rivaroxaban
In a surprise announcement by the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), Rivaroxaban is being recommended for acute coronary syndrome indication. Rivaroxaban, an anticoagulant...
Study Suggests Hospital Stays may be Shorter When AF Patients Given Dabigatran
According to a small retrospective study, AF patients may help reduce the amount of time spent in the hospital when they are given Dabigatran. The reason for this is because...
Study: Digoxin Increases AF Patient Mortality Rates
A new study has found that AF patients who take digoxin for the first time showed an increased mortality rate when compared to non-digoxin patients. This information was reported at...
Study: Stroke Risks for AF Patients Increases When Patients Stop Taking Rivaoxaban, Warfarin
According to a new study, which was presented at the American College of Cardiology’s 2013 Scientific Sessions on March 10, 2013, patients experiencing atrial fibrillation (AF) who stop taking either...